News from TCT 2006 – Latest data on drug-eluting stent controversy

An abundance of new information on the controversy surrounding drug-eluting stents was presented and discussed at the Transcatheter and Therapeutics (TCT) meeting held in Washington DC, US, in October. The controversy, which dominated the World Congress of Cardiology, in Barcelona, Spain, the previous month, centres around concern about a possible increase in late stent thrombosis leading to death and myocardial infarction (MI) in patients receiving drug-eluting stents.